The Effect of İnhaler Training and Reminders on Medication on Adherence in Elderly Individuals
The Effect Of Metered-Dose İnhaler Training And Reminders On Medication Adherence In Elderly Individuals: A Randomized Controlled Study
1 other identifier
interventional
64
1 country
1
Brief Summary
This study will evaluate the effect of metered-dose inhaler training and reminders on treatment adherence in elderly individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 21, 2026
CompletedFirst Submitted
Initial submission to the registry
January 24, 2026
CompletedFirst Posted
Study publicly available on registry
February 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
March 9, 2026
March 1, 2026
4 months
January 24, 2026
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Metered Dose Inhaler Skill
The "Measured Dose Inhaler Skill Chart" involves evaluating the participant's inhaler usage and checking the application steps. Performing all steps correctly will be considered "correct inhaler technique," while performing at least one or more steps incorrectly or not at all will be considered "incorrect inhaler technique." For each step, incorrect application or omission will receive "0 points," and correct application will receive "1 point," resulting in a total score between "0 and 10." Participants who make at least "1 mistake" or score "below 10" will be included in the study. When evaluating scores based on inhaler usage steps, "0-3" points will be considered poor, "4-6" points moderate, and "7-10" points good.
the initial screening and three months after the initial screening (three months)
Medication Adherence Reporting Scale
The scale consists of 5 items in total. The total test score is determined by summing the scores obtained from the items. Scores obtained from the scale range from 5 to 25. Higher total scores indicate better medication adherence, while lower total scores indicate poor medication adherence.
the initial screening and three months after the initial screening (three months)
Study Arms (2)
arm description experimental
EXPERIMENTALThe socio-demographic and descriptive characteristics, as well as questions regarding medication adherence, included in the survey form will be answered through face-to-face interviews. While the participant demonstrates how to apply the inhaler, the researcher will evaluate the participant's inhaler use according to the "Metered Dose Inhaler Skill Chart," which includes the steps for inhaler use. Each participant in the experimental group will receive metered-dose inhaler training using a demonstration method. At the end of the training, participants will be given a "Metered Dose Inhaler Use Reminder Card" and a "Metered Dose Inhaler Application Video." Participants will also receive weekly reminders via telephone. After 3 months, the experimental group will be contacted via video call to demonstrate how they use the inhaler. The researcher will evaluate the participants' medication adherence scores and record them on the survey form. If any steps are incorrectly applied, the metered
arm description control
NO INTERVENTIONThe socio-demographic and demographic characteristics, as well as questions regarding medication adherence, included in the survey form will be answered through face-to-face interviews. While the participant demonstrates how to apply the inhaler, the researcher will evaluate the participant's inhaler use according to the "Metered Dose Inhaler Skill Chart," which includes the steps for inhaler use. No inhaler training or reminders will be given. Participants in the control group will be contacted by phone 3 months after the initial follow-up and asked to demonstrate how they use the inhaler. The researcher will evaluate the participants' medication adherence scores and record them on the survey form. After the data collection is complete, inhaler training will be given to the participants using a demonstration method. At the end of the training, reminder cards and a video demonstrating metered-dose inhaler application will be shared with the participants.
Interventions
It is known that incorrect inhaler use is more common, especially in elderly individuals, and that common errors in metered-dose inhaler use include poor hand-mouth coordination, inability to simultaneously spray and inhale, and failure to hold the breath during inhalation. This study evaluates metered-dose inhaler use only in elderly individuals. Furthermore, not only will the inhaler application steps be evaluated, but the experimental group will also receive education and reminder interventions.
This reminder card contains the inhaler administration steps included in the "Measured Dose Inhaler Medication Use Skill Chart". Participants in the experimental group will be able to access the medication administration steps on the reminder card before administering their inhaler medication. Participants will be asked in the final interview whether they used the reminder cards.
This video was prepared by the responsible researcher, taking into account the application steps included in the "Metered Dose Inhaler Medication Use Skill Chart". Participants in the experimental group will be able to access the application steps via the inhaler video before administering their inhaler medication.
Eligibility Criteria
You may qualify if:
- Age ≥ 65 years old
- Having at least basic literacy,
- Receiving metered-dose inhaler therapy for at least 6 months,
- Being hospitalized in the pulmonary ward,
- Presenting to the pulmonary function test unit,
- Presenting to the pulmonary outpatient clinic,
- Signing the informed consent form for participation in the study,
- Having internet access and a mobile device with Android/iOS operating system,
- Being able to use a telephone,
- Having no communication barriers,
- Being able to use the inhaler without needing assistance,
- Making an error in at least one of the usage steps according to the MDI usage skills chart.
You may not qualify if:
- Age \<65
- Illiteracy
- Receiving metered-dose inhaler therapy for \<6 months
- Outpatient treatment
- Being hospitalized in the intensive care unit
- Being hospitalized in wards other than the pulmonary ward (such as surgery, physical therapy)
- Visiting outpatient clinics other than the pulmonary clinic (such as surgery, physical therapy)
- Not signing the informed consent form for participation in the study
- Not having internet access and a mobile device with Android/iOS operating system
- Not having telephone skills
- Having communication barriers
- Requiring assistance while using the inhaler
- Not making any errors in the usage steps according to the MDI usage skills chart
- Wanting to withdraw from the study/withdrawing from participation during the research process
- Not completing the questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University
Çanakkale, 17100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sevda Ateş, Associate Professor
Çanakkale Onsekiz Mart University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 24, 2026
First Posted
February 2, 2026
Study Start
January 21, 2026
Primary Completion (Estimated)
May 23, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
In the ethics committee approval and institutional permission obtained for the study, I stated that the study would not be shared anywhere other than for publication.